Rituximab-containing reduced-intensity conditioning improves progression-free survival following allogeneic transplantation in B cell non-Hodgkin lymphoma

BACKGROUND: In B cell non-Hodgkin lymphoma (B-NHL), rituximab-containing reduced-intensity conditioning regimens (R-RIC) have been shown to provide favorable outcomes in single-arm studies; however, large multicenter studies comparing R-RIC and non-rituximab-containing reduced-intensity conditioning...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Hematol Oncol
Main Authors: Epperla, Narendranath, Ahn, Kwang Woo, Ahmed, Sairah, Jagasia, Madan, DiGilio, Alyssa, Devine, Steven M., Jaglowski, Samantha, Kennedy, Vanessa, Rezvani, Andrew R., Smith, Sonali M., Sureda, Anna, Fenske, Timothy S., Kharfan-Dabaja, Mohamed A., Armand, Phillipe, Hamadani, Mehdi
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2017
Teme:
Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5469142/
https://ncbi.nlm.nih.gov/pubmed/28606176
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13045-017-0487-y
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki